Capitalization 9.76B 13.44B P/E ratio 2024 *
-1.36x
P/E ratio 2025 * 12.1x
Enterprise value 30.17B 41.57B EV / Sales 2024 *
0.12x
EV / Sales 2025 * 0.11x
Free-Float
60.8%
Yield 2024 *
11.2%
Yield 2025 * 8.85%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.62%
1 week-4.26%
Current month-7.15%
1 month-29.42%
3 months-37.78%
6 months-50.27%
Current year-56.99%
More quotes
1 week
10.80
Extreme 10.8
12.02
1 month
10.69
Extreme 10.69
16.25
Current year
10.69
Extreme 10.69
27.05
1 year
10.69
Extreme 10.69
31.32
3 years
10.69
Extreme 10.69
55.00
5 years
10.69
Extreme 10.69
64.50
10 years
10.69
Extreme 10.69
97.30
More quotes
Manager TitleAgeSince
Director of Finance/CFO 45 16-01-31
Chief Operating Officer 69 14-11-30
Corporate Officer/Principal - 21-10-28
Director TitleAgeSince
Chairman 83 12-07-31
Director/Board Member 66 12-03-31
Director/Board Member 69 06-09-30
More insiders

Other Drug Retailers

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.62%-4.26%-63.35%-75.87% 9.76B
-2.13%-4.18%-60.48%-80.01% 8.62B
-2.70%+0.31%-35.84%-77.69% 6.86B
-1.54%+0.67%-8.49%+46.52% 6.64B
+1.03%-1.52%+110.41%+198.25% 5.23B
+0.30%-0.15%-25.22% - 4.61B
-0.84%-3.13%+31.62%+30.01% 4.48B
-4.12%-2.30%-28.32%-25.79% 3.85B
-1.00%-1.99%+32.82%-0.22% 3.09B
-2.72%+1.72%-27.18%-45.79% 2.69B
Average -1.43%+0.08%-7.40%-3.40% 5.58B
Weighted average by Cap. -1.37%-0.26%-16.48%-13.78%
See all sector performances
Ratios2024 *2025 *
Net sales 146B 201B 148B 204B
Net income -6.94B -9.56B 770M 1.06B
Net Debt 7.38B 10.17B 6.75B 9.29B
More financial data * Estimated data
Logo Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Employees
268,500
Calendar
Related indices
More about the company
Date Price Change Volume
24-07-23 11.23 $ -0.62% 14,323,443
24-07-22 11.30 $ +2.63% 22,281,403
24-07-19 11.01 $ -3.08% 80,864,506
24-07-18 11.36 $ -4.14% 19,829,427
24-07-17 11.85 $ +1.02% 17,910,977

Delayed Quote Nasdaq, July 23, 2024 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
11.30USD
Average target price
13.87USD
Spread / Average Target
+22.74%
Consensus